Friday 6 November 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025.

Revenue: +1.33%
EPS: +418.2%
Free cash flow: −6.83%
Total debt: −42.2%

Quarter to June 2026, against a year earlier

72.76 0.10 +0.14%

Follow TECH

Alert me

Market cap: $11.4B
P/E: 62.2×
Fwd P/E: 54.2×
Dividend yield: 0.44%
F-score: 9/9
Altman Z: 15.50
Beneish M: −2.52
Dividend safety: 78/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	60.38	73.61	113.10	111.26	+8 more quarters Free account
P/S ratio Full definition →	9.07	6.75	7.54	7.11
P/FCF ratio Full definition →	41.86	30.30	41.09	38.60
P/Operating CF Full definition →	115.48	94.27	111.21	313.52
P/B ratio Full definition →	5.23	3.92	4.56	4.40
Price to Tangible BV Full definition →	13.29	10.36	13.18	13.58
EV/Sales Full definition →	9.03	6.75	7.62	7.25
EV/EBITDA Full definition →	31.40	32.16	41.98	40.81
EV/Operating CF Full definition →	37.55	27.72	37.16	35.09
EV/FCF Full definition →	41.66	30.31	41.54	39.35
Quick Ratio Full definition →	2.94	2.77	2.55	2.28
Current Ratio Full definition →	4.55	4.49	4.54	4.22
Net Debt/EBITDA Full definition →	(0.66)	(0.10)	1.10	2.15
Debt/Assets Full definition →	7.73%	7.84%	10.31%	11.88%
Debt/Equity Full definition →	0.09	0.10	0.13	0.15
Asset Turnover Full definition →	0.47	0.47	0.47	0.46
Operating CF/Net income Full definition →	1.75	1.70	2.17	0.72
Capex/Depreciation Full definition →	(0.35)	(0.38)	(0.24)	(0.22)
Research and Development Expense of Revenue Full definition →	7.46%	7.53%	7.82%	8.46%
Selling, General and Administrative Expense of Revenue Full definition →	35.24%	35.11%	38.43%	40.56%
Intangible Assets out of Total Assets Full definition →	0.49	0.51	0.52	0.53
Share Based Compensation of Revenue Full definition →	1.63%	3.37%	4.72%	4.08%
Graham Net Nets Full definition →	0.02	0.03	0.01	0.01
Graham Number Full definition →	18.86	14.60	12.29	11.93
Earnings Yield Full definition →	1.66%	1.36%	0.88%	0.90%
Free Cash Flow Yield Full definition →	2.39%	3.30%	2.43%	2.59%
Revenue per Share Full definition →	2.06	1.99	1.90	1.84
Operating CF per Share Full definition →	0.61	0.55	0.53	0.18
Capex per Share Full definition →	(0.05)	(0.06)	(0.04)	(0.03)
Free Cash Flow per Share Full definition →	0.56	0.50	0.49	0.14
Cash per Share Full definition →	1.70	1.34	1.11	0.93
Shareholders Equity per Share Full definition →	13.52	13.34	12.90	12.64
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	13.52	13.34	12.90	12.64
Free Cash Flow Full definition →	86.94	77.58	76.49	22.22
Working Capital Full definition →	580.70	534.77	497.01	464.96
Capital Expenditures Full definition →	(8.48)	(9.09)	(5.92)	(5.36)
Net Current Asset Value Full definition →	265.90	222.75	125.72	49.17
EV/EBIT Full definition →	43.54	53.15	79.21	80.20
Capex to Sales Full definition →	0.03	0.03	0.02	0.02
Price to Operating Income Full definition →	43.74	53.13	78.35	78.68
Other line items
Average Receivables Full definition →	211.73	225.85	201.28	203.79
Average Payables Full definition →	26.01	27.57	29.69	30.86
Average Inventory Full definition →	192.60	196.13	196.91	194.11
Average Assets Full definition →	2,572.30	2,597.43	2,596.56	2,631.08
Average Common Equity Full definition →	2,013.51	2,051.66	2,044.74	2,052.23

Show all line items

Columns are period end dates

Stockrow Weekly